Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
The present invention discloses novel compounds of Formula I: (I) having 11-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as methods of using the c...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Bush, Julie Kay Hansen, Marvin Martin Li, Renhua Mabry, Thomas Edward Snyder, Nancy June Wallace, Owen Brendan Xu, Yanping |
description | The present invention discloses novel compounds of Formula I: (I) having 11-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as methods of using the compounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, and other conditions associated with 11-HSD type 1 activity. |
format | Patent |
fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_08153807</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>08153807</sourcerecordid><originalsourceid>FETCH-uspatents_grants_081538073</originalsourceid><addsrcrecordid>eNrjZDDxzMvITMosyS8qVshPUzA01E1KLUnUzahMKcqvqCwuSS3Kz0xRSEkFC6Sn5iUWpyoY8jCwpiXmFKfyQmluBgU31xBnD93S4oLEktS8kuL49KJEEGVgYWhqbGFgbkyEEgDn2y11</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1</title><source>USPTO Issued Patents</source><creator>Bush, Julie Kay ; Hansen, Marvin Martin ; Li, Renhua ; Mabry, Thomas Edward ; Snyder, Nancy June ; Wallace, Owen Brendan ; Xu, Yanping</creator><creatorcontrib>Bush, Julie Kay ; Hansen, Marvin Martin ; Li, Renhua ; Mabry, Thomas Edward ; Snyder, Nancy June ; Wallace, Owen Brendan ; Xu, Yanping ; Eli Lilly and Company</creatorcontrib><description>The present invention discloses novel compounds of Formula I: (I) having 11-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as methods of using the compounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, and other conditions associated with 11-HSD type 1 activity.</description><language>eng</language><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8153807$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64012</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8153807$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Bush, Julie Kay</creatorcontrib><creatorcontrib>Hansen, Marvin Martin</creatorcontrib><creatorcontrib>Li, Renhua</creatorcontrib><creatorcontrib>Mabry, Thomas Edward</creatorcontrib><creatorcontrib>Snyder, Nancy June</creatorcontrib><creatorcontrib>Wallace, Owen Brendan</creatorcontrib><creatorcontrib>Xu, Yanping</creatorcontrib><creatorcontrib>Eli Lilly and Company</creatorcontrib><title>Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1</title><description>The present invention discloses novel compounds of Formula I: (I) having 11-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as methods of using the compounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, and other conditions associated with 11-HSD type 1 activity.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZDDxzMvITMosyS8qVshPUzA01E1KLUnUzahMKcqvqCwuSS3Kz0xRSEkFC6Sn5iUWpyoY8jCwpiXmFKfyQmluBgU31xBnD93S4oLEktS8kuL49KJEEGVgYWhqbGFgbkyEEgDn2y11</recordid><startdate>20120410</startdate><enddate>20120410</enddate><creator>Bush, Julie Kay</creator><creator>Hansen, Marvin Martin</creator><creator>Li, Renhua</creator><creator>Mabry, Thomas Edward</creator><creator>Snyder, Nancy June</creator><creator>Wallace, Owen Brendan</creator><creator>Xu, Yanping</creator><scope>EFH</scope></search><sort><creationdate>20120410</creationdate><title>Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1</title><author>Bush, Julie Kay ; Hansen, Marvin Martin ; Li, Renhua ; Mabry, Thomas Edward ; Snyder, Nancy June ; Wallace, Owen Brendan ; Xu, Yanping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_081538073</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Bush, Julie Kay</creatorcontrib><creatorcontrib>Hansen, Marvin Martin</creatorcontrib><creatorcontrib>Li, Renhua</creatorcontrib><creatorcontrib>Mabry, Thomas Edward</creatorcontrib><creatorcontrib>Snyder, Nancy June</creatorcontrib><creatorcontrib>Wallace, Owen Brendan</creatorcontrib><creatorcontrib>Xu, Yanping</creatorcontrib><creatorcontrib>Eli Lilly and Company</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Bush, Julie Kay</au><au>Hansen, Marvin Martin</au><au>Li, Renhua</au><au>Mabry, Thomas Edward</au><au>Snyder, Nancy June</au><au>Wallace, Owen Brendan</au><au>Xu, Yanping</au><aucorp>Eli Lilly and Company</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1</title><date>2012-04-10</date><risdate>2012</risdate><abstract>The present invention discloses novel compounds of Formula I: (I) having 11-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as methods of using the compounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, and other conditions associated with 11-HSD type 1 activity.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_uspatents_grants_08153807 |
source | USPTO Issued Patents |
title | Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T08%3A39%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Bush,%20Julie%20Kay&rft.aucorp=Eli%20Lilly%20and%20Company&rft.date=2012-04-10&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E08153807%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |